ABC | Volume 111, Nº1, Julho 2018

Minieditorial Silva et al Carga econômica das doenças cardiovasculares no brasil Arq Bras Cardiol. 2018; 111(1):37-38 Portanto, apesar da relevância do tema, o estudo de Stevens et al. não traz informações convincentes nem sobre a carga das doenças selecionadas nem sobre a razão de custo-efetividade da telemedicina ou do contato telefônico estruturado para a abordagem dessas condições. Ele tem limitações importantes que impedem que seus resultados sejam interpretados de forma clara e aplicados no cenário nacional de maneira abrangente. 1. Stevens B, Pezzullo L, Verdian L, Tomlinson J, George A, Bacal F. Deloitte Access Economics Pty Ltd. Os custos das doenças cardíacas no Brasil. Arq Bras Cardiol. 2018; 111(1):29-36. 2. Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093-103. 3. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al; CHEERS Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care. 2013;29(2):117-22. 4. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211-59. 5. Duncan BB, França EB, Passos VM, Cousin E, Ishitani LH, Malta DC, et al. The burden of diabetes and hyperglycemia in Brazil and its states: findings from the Global Burden of Disease Study 2015. Rev Bras Epidemiol. 2017;20Suppl 01(Suppl 01):90-101. 6. Szwarcwald CL, Souza Junior PR, Marques AP, Almeida WD, Montilla DE. Inequalities in healthy life expectancy by Brazilian geographic regions: findings from the National Health Survey, 2013. Int J Equity Health. 2016;15(1):141. 7. de Andrade LO, Pellegrini Filho A, Solar O, Rígoli F, de Salazar LM, Serrate PC, et al. Social determinants of health, universal health coverage, and sustainable development: case studies from Latin American countries. Lancet. 2015;385(9975):1343-51. 8. Stevens B, Pezzullo L, Verdian L, Tomlinson J, George A, Parejo JA. La carga económica de las condiciones cardíacas en Venezuela. Med Interna (Caracas). 2017;33(1):42-50. 9. Stevens B, Pezzullo L, Verdian L, Tomlinson J, Estrada-Aguilar C, George A, et al. The economic burden of hypertension, heart failure, myocardial infarction, and atrial fibrillation inMexico. Arch Cardiol Mex. 2018 Apr 11. [Epub ahead of print]. 10. Shafie AA, Tan YP, Ng CH. Systematic review of economic burden of heart failure. Heart Fail Rev. 2018;23(1):131-45. 11. Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012;7(10):e48255. 12. Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, et al. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation. Health Technol Assess. 2013;17(32):1-207, v-vi. 13. Brasil. Senado Federal. Congresso Nacional aprova orçamento de 2015. [Citadoem2017 jan10].Disponívelem :https://www.senado.leg.br/noticias/ materias/2015/03/17/congresso-nacional-aprova-prcamento-de-2015. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 38